Pancreatic Cancer

  • RTOG 0848 (SOMC Pending)– Phase III Trial Evaluating both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (Arm 2 Closed to Accrual)
  • ECOG E2211– Phase II Randomized Study of Temozolomide or Temozolomide and Cepecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors
  • SWOG S1505– A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma